p38 MAP kinases: Beyond the stress response

Trends in Biochemical Sciences

Volumn 25, Issue 6, 2000, Pages 257-260

  Nebreda, Angel R ^a   Porras, Almudena ^b  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; DEVELOPMENT; ENZYME ACTIVATION; FLY; MORPHOGENESIS; NONHUMAN; OOCYTE DEVELOPMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; VERTEBRATE;

VERTEBRATA;

EID: 0034213138     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(00)01595-4     Document Type: Short Survey

References (27)

1. Adachi-Yamada T.et al. p38 mitogen-activated protein kinase can be involved in transforming growth factor beta superfamily signal transduction in Drosophila wing morphogenesis. Mol. Cell. Biol. 19:1999;2322-2329.
2. Suzanne M.et al. The Drosophila p38 MAPK pathway is required during oogenesis for egg asymmetric development. Genes Dev. 13:1999;1464-1474.
3. Engelman J.A.et al. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J. Biol. Chem. 273:1998;32111-32120.
4. Engelman J.A.et al. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis. J. Biol. Chem. 274:1999;35630-35638.
5. Wang X.Z., Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science. 272:1996;1347-1349.
6. Cuenda A., Cohen P. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274:1999;4341-4346.
7. Galbiati F.et al. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. J. Biol. Chem. 274:1999;30315-30321.
8. Zetser A.et al. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274:1999;5193-5200.
9. Puri P.L.et al. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 14:2000;574-584.
10. Morooka T., Nishida E. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J. Biol. Chem. 273:1998;24285-24288.
11. Iwasaki S.et al. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J. Biol. Chem. 274:1999;26503-26510.
12. Maher P. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J. Biol. Chem. 274:1999;17491-17498.
13. Nakamura K.et al. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp. Cell Res. 250:1999;351-363.
14. Nagata Y.et al. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood. 92:1998;1859-1869.
15. McKinsey T.A., Olson E.N. Cardiac hypertrophy: sorting out the circuitry. Curr. Opin. Genet. Dev. 9:1999;267-274.
16. Kolodziejczyk S.M.et al. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr. Biol. 9:1999;1203-1206.
17. Rausch O., Marshall C.J. Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hematopoietic cell proliferation. J. Biol. Chem. 274:1999;4096-4105.
18. MAPK pathway. J. Biol. Chem. 271:1996;20608-20616.
19. 1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272:1997;13229-13235.
20. Ellinger-Ziegelbauer H.et al. Cell cycle arrest and reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3. Mol. Cell. Biol. 19:1999;3857-3868.
21. Le-Niculescu H.et al. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 19:1999;751-763.
22. Zechner D.et al. MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J. Biol. Chem. 273:1998;8232-8239.
23. Mackay K., Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein protects neonatal cardiac myocytes from ischemia. J. Biol. Chem. 274:1999;6272-6279.
24. Wang Y.S.et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273:1998;2161-2168.
25. Nemoto S.et al. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. J. Biol. Chem. 273:1998;16415-16420.
26. Mao Z.et al. Neuronal activity-dependent cell survival mediated by MEF2. Science. 286:1999;785-790.
27. Eyers P.A.et al. Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580. FEBS Lett. 451:1999;191-196.